Drug Trial Radar · NCT06911866
A Phase Ib Study of RC1416 Injection
Last checked: Nov 19, 2026Latest source record: Jan 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
40
Actual
Start
Oct 25, 2024
Primary completion
Sep 25, 2025
Study completion Sep 25, 2025
Sponsor
- Lead sponsor
- Nanjing RegeneCore Biotech Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Apr 4, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase Ib study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity and preliminary efficacy of RC1416 injection in patients with moderate to severe asthma.
Conditions
- Moderate to Severe Asthma
Interventions
RC1416Drug
there are four doses(200mg-400mg) in this part. Each subjects will receive the drug once by subcutaneous injection.
RC1416 PlaceboDrug
Each subjects will receive the placebo once by subcutaneous injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- AETime frame: up to 141 days
- SAETime frame: up to 141 days
- Vital SignsTime frame: up to 141 days
- Laboratory TestsTime frame: up to 141 days
- ECGTime frame: up to 141 days
- Injection Site ReactionTime frame: up to 85 days
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China
Peking University Shougang Hospital
Beijing, Beijing Municipality, China
Shenzhen People's Hospital
Shenzhen, Guangdong, China
The First Affiliated Hospital of Guilin Medical University
Guilin, Guangxi, China
Hebei Petro China Centre Hospital
Langfang, Hebei, China
Hebei Province Hospital of Chinese Medicine
Shijiazhuang, Hebei, China
Nanyang Central Hospital
Nanyang, Henan, China
Xinxiang First People's Hospital
Xinxiang, Henan, China
The First Affiliated Hospital of Baotou Medical College
Baotou, Inner Mongolia, China
Nanjing First Hospital
Nanjing, Jiangsu, China
Jining NO.1 people's hospital
Jining, Shandong, China
Liaocheng People's Hospital
Liaocheng, Shandong, China
Zibo Municipal Hospital
Zibo, Shandong, China
Shanxi Bethune Hospital
Taiyuan, Shanxi, China
Hangzhou First People's Hospital
Hangzhou, Zhejiang, China
The Second Affiliated Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.